Sector: Pharmaceuticals & Biotechnology

Small Cap

Norris Medicines Share Price

Q: What is the Market Capitalization of Norris Medicines Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Norris Medicines Ltd. is approximately ₹ 13.5 Cr.

Q: What are the PE and PB ratios for Norris Medicines Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Norris Medicines Ltd. is -48.2, and the Price-to-Book (PB) ratio is -0.9.

Q: What is the 52-Week High and Low for Norris Medicines Ltd.?

Over the past 52 weeks, the highest price reached by Norris Medicines Ltd. shares was ₹ 19.25, and the lowest price was ₹ 12.

Q: Who are the major shareholders of Norris Medicines Ltd.?

Significant shareholdings in Norris Medicines Ltd. typically include entities such as: Public Promoter Other Institutions Mutual Funds (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Norris Medicines Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Norris Medicines Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Norris Medicines Ltd.

₹13.51

0.16(1.20%)

25th Jun 2026 | 3:09 PM

NSE :

Open Free Demat Account

Norris Medicines Performance

Price Movement

N/A

₹13.50

₹14.10

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹14.10

Low₹13.50

Open at₹14.00

Prev Close₹13.35

Volumes452

Avg Price₹13.71

Lower Circuit₹12.19

Upper Circuit₹14.89

Historical Performance

3M High₹15.67

3M Low₹12.25

1 Yr High₹19.25

1 Yr Low₹12.00

3 Yr High₹27.74

3 Yr Low₹10.05

5 Yr High₹36.75

5 Yr Low₹5.75

Summary

As of 26-06-2026 03:14, Norris Medicines Ltd. share price today is ₹0, with a change of ₹-13.35 (-100.00%) from the previous close of ₹13.35. The stock opened at ₹14 and traded between ₹13.5 and ₹14.1, with a total traded volume of 452 shares. The company has a market capitalization of ₹13.5 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹19.33 and ₹12, respectively.

Norris Medicines Ltd. valuation metrics include a P/E ratio of -48.2, and book value of ₹-0.90. Norris Medicines Ltd. has reported revenue of ₹8.13 Cr and net profit of ₹-0.28 Cr.

Norris Medicines Ltd. technical indicators include Day RSI at 48.51, Day MFI at 66.89, Day ADX at 13.06. Additional indicators include Commodity Channel Index (CCI) at -21.2 and Williams %R at -64. Momentum indicators show Day MACD at -0.05, Day MACD Signal Line at -0.03, DayATR at 0.94. Rate of Change indicators for Norris Medicines Ltd. include ROC125 at -17.49 and ROC21 at -4.58.

Exponential moving averages include EMA5 at ₹13.6, EMA10 at ₹13.6, EMA12 at ₹13.7, EMA20 at ₹13.7, EMA26 at ₹13.7, EMA50 at ₹13.8, EMA100 at ₹14.1, EMA200 at ₹14.8. Simple moving averages include SMA5 at ₹13.7, SMA10 at ₹13.7, SMA20 at ₹13.7, SMA30 at ₹13.6, SMA50 at ₹14, SMA100 at ₹13.9, SMA150 at ₹14.4, SMA200 at ₹14.8.

Support levels for Norris Medicines are placed at First Support ₹13.33, Second Support ₹13.11, Third Support ₹12.73. Resistance levels are seen at First Resistance ₹13.93, Second Resistance ₹14.31, Third Resistance ₹14.53. Norris Medicines Ltd. shareholding pattern shows promoter holding at 34.01%, FII holding at 0%, DII holding at 0%, public holding at 65.9%.

Norris Medicines Fundamentals

Market Cap

Low in industry

13.50 Cr.

PE Ratio (TTM)

Negative PE TTM

-48.20

Dividend Yield

Net Profit TTM

77.4% incr over last year

-0.28

Net Profit Growth

77.4% incr over last year

-0.28

PEG Ratio

Negative PEG TTM

-0.60

ROE

Operating Revenue TTM

8.13

Operating Revenue Growth

39.7% incr over last year

Book Value

Negative Price to Book

-0.90

MFI

MFI is mid-range

66.89

RSI

RSI is mid-range

48.51

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

-0.90

Norris Medicines Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	1.41	3.27	2	1.46	2.72
Operating Expense	1.10	2.32	2.49	1.56	2.65
Operating Profit	0.31	0.95	-0.49	-0.10	0.07
Depreciation	0.12	0.12	0.12	0.12	0.14
Interest	0.15	0.13	0.11	0.11	0.15
Tax	0	0	0	0	0.06
Net Profit	0.05	0.70	-0.72	-0.31	-0.23

Norris Medicines Technicals

Norris Medicines Ltd. EMA & SMA

₹13.51

0.16 (1.20%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹13.6

Day EMA10 ₹13.6

Day EMA12 ₹13.7

Day EMA20 ₹13.7

Day EMA26 ₹13.7

Day EMA50 ₹13.8

Day EMA100 ₹14.1

Day EMA200 ₹14.8

Norris Medicines Support and Resistance

Resistance

First Resistance₹13.93

Second Resistance₹14.31

Third Resistance₹14.53

Support

First Support₹13.33

Second Support₹13.11

Third Support₹12.73

Technical Indicators

Day RSI48.51

Day MFI66.89

Day ADX13.06

Day Commodity Channel Index-21.20

William-64.00

Day MACD-0.05

Day MACD Signal Line-0.03

Day ATR0.94

Day ROC125-17.49

Day ROC21-4.58

Norris Medicines Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	34	34	34	34	34	34
FII	0	0	0	0	0	0
DII	0.1	0.1	0.1	0.1	0.1	0.1
Public	65.9	65.9	65.9	65.9	65.9	65.9

Norris Medicines Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	402	452	88.72%
Week	1.26 K	1.36 K	92.59%
1 Month	1.57 K	1.89 K	82.92%
6 Month	992	1.2 K	82.84%

Norris Medicines SWOT Analysis

Strengths10

Weakness10

Opportunity0

Threats0

Relative Outperformance versus Industry over 1 Month

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Month

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Companies with Zero Promoter Pledge

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Stock with Low PE (PE < = 10)

Top Gainers

Norris Medicines Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Norris Medicines Stock Comparison

Financials	Goldline Pharmaceutical Ltd.	Sai Parenterals Ltd.	Speciality Medicines Ltd.	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.
Price (₹)	₹43.20	₹588	₹201	₹258.80	₹35.50	₹5.70
% Change	-3.76%	-0.30%	-1.95%	-2.34%	-1.33%	-1.04%
Revenue TTM (₹ Cr)	-	-	-	-	₹1.27	₹83.60
Net Profit TTM (₹ Cr)	-	-	-	-	₹-0.25	₹-34.95
PE TTM	10.10	-	13.50	37.00	-84.00	-1.40
1 Year Return		49.31			688.89	471
ROCE	-	3.56	-	-	-	-5.63

Similar Stocks

APPL

Aptus Pharma Ltd.

₹ 235.15

+0.73%

AMANTA

Amanta Healthcare Ltd.

₹ 162.00

-0.52%

AHCL

Anlon Healthcare Ltd.

₹ 16.37

+1.49%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 93.60

+1.15%

APL

Asston Pharmaceuticals Ltd.

₹ 81.00

-1.22%

UNICHEMLAB

Unichem Laboratories Ltd.

₹ 432.60

-0.22%

FERMENTA

Fermenta Biotech Ltd.

₹ 364.25

-0.26%

GENPHARMA

Genpharmasec Ltd.

₹ 1.11

-2.63%

KILITCH

Kilitch Drugs(I) Ltd.

₹ 185.00

-3.05%

MEDICO

Medico Remedies Ltd.

₹ 40.00

-2.56%

CONCORD

Concord Drugs Ltd.

₹ 76.40

+1.61%

PHARMAID

Pharmaids Pharmaceuticals Ltd.

₹ 36.00

+4.93%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 305.80

-1.61%

KIMIABL

Kimia Biosciences Ltd.

₹ 33.74

+4.88%

CORALAB

Coral Laboratories Ltd.

₹ 625.00

-3.52%

JENBURPH

Jenburkt Pharmaceuticals Ltd.

₹ 1126.60

-0.13%

KPL

Kwality Pharmaceuticals Ltd.

₹ 2436.70

-0.54%

MEDICAMEQ

Medicamen Biotech Ltd.

₹ 228.00

-0.61%

GVBL

Genomic Valley Biotech Ltd.

₹ 33.36

-4.98%

UNJHAFOR

Unjha Formulations Ltd.

₹ 19.00

+0.00%

NECLIFE

Nectar Lifesciences Ltd.

₹ 11.48

-0.52%

ANG

ANG Lifesciences India Ltd.

₹ 42.21

+1.93%

BROOKS

Brooks Laboratories Ltd.

₹ 73.20

-4.69%

FAQ's on NORRIS

What is the Market Capitalization of Norris Medicines Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Norris Medicines Ltd. is approximately ₹ 13.5 Cr.

What are the PE and PB ratios for Norris Medicines Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Norris Medicines Ltd. is -48.2, and the Price-to-Book (PB) ratio is -0.9.

What is the 52-Week High and Low for Norris Medicines Ltd.?

Over the past 52 weeks, the highest price reached by Norris Medicines Ltd. shares was ₹ 19.25, and the lowest price was ₹ 12.

Who are the major shareholders of Norris Medicines Ltd.?

Significant shareholdings in Norris Medicines Ltd. typically include entities such as:

Public
Promoter
Other Institutions
Mutual Funds

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Norris Medicines Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Norris Medicines Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy